Synthesis of somatostatin analogues containing C-terminal adamantane and their antiproliferative properties

Journal of Medicinal Chemistry

Volumn 51, Issue 16, 2008, Pages 5121-5124

  Miyazaki, Anna ^a   Tsuda, Yuko ^a   Fukushima, Shoji ^a   Yokoi, Toshio ^a   Vántus, Tibor ^b   Bökönyi, Gyöngyi ^b   Szabó, Edit ^b   Horváth, Anikó ^b   Kéri, György ^b   Okada, Yoshio ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ADAMANTANE; DNA; PEPTIDE DERIVATIVE; SOMATOSTATIN DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL LINE; DNA FRAGMENTATION; DRUG SYNTHESIS; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL;

ADAMANTANE; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL PROLIFERATION; HUMANS; SOMATOSTATIN; TUMOR CELLS, CULTURED;

EID: 50249143441     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm701599w     Document Type: Article

References (22)

1. Brazeau, P.; Vale, W.; Burgus, R.; Ling, N.; Butcher, M.; Rivier, J.; Guillemin, R. Hypothalamic polypeptide that inhibits the secretion of immnoreactive pituitary growth hormone. Science 1973, 179, 77-79.
2. Reichilin, S.; Somatostatin, N. N. Engl. J. Med. 1983, 309, 1556-1563.
3. Patel, Y. C.; Srikant, C. B. Somatostatin mediation of adenohypophysical secretion. Annu. Rev. Physiol. 1986, 48, 551-567.
4. Colas, B.; Cambilleu, C.; Buscail, L.; Zeggari, M.; Esteve, J. P.; Lautre, V.; Thomas, F.; Vaysse, N.; Susini, C. Stimulation of a membrane tyrosine phosphatase activity by somatostatin analogues in rat pancreatic acinar cells. Eur. J. Biochem. 1992, 207, 1017-1024.
5. Pan, M. G.; Florio, T.; Stock, P. J. G-Protein activation of a hormone-stimulated phosphatase in human tumor cells. Science 1992, 256, 1215-1217.
6. Breader, C. D.; Yamada, Y. Y.; Yasuda, K.; Seino, S.; Saper, C. B.; Bell, G. I. Differential expression of somatostatin receptor subtypes in brain. J. Neurosci. 1992, 12, 3920-3934.
7. Bruno, J. F.; Xu, Y.; Song, J.; Berelowitz, M. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. Endocrinology 1993, 133, 2561-2567.
8. Lamberts, S. W. Somatostatin and somatostatin analogues: diagnostic and therapeutic uses. Curr. Opin. Oncol. 2002, 14, 53-57.
9. Bauer, W.; Briner, U.; Doepfner, W.; Haller, R.; Huguenin, R.; Marbach, P.; Petcher, T. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci. 1982, 31, 1133-1140.
10. Setyono-Han, B.; Henkelman, M. S.; Foekens, J. A.; Kllin, G. M. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res. 1987, 47, 1566-1570.
11. Schally, A. V.; Redding, T. W. Somatostatin analogs as adjuncts to agonist of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 7275-7279.
12. Cai, R. Z.; Szoke, B.; Lu, R.; Fu, D.; Redding, T. W.; Schally, A. V. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin. Proc. Natl. Acad. Sci. U.S.A. 1986, 83, 1896-1900.
13. Kaupmann, K.; Bruns, C.; Raulf, F.; Weber, H. P.; Mattes, H.; Lubbert, H. Two amino acids, located in transmembrane domains VI and VII, determine the selectivity of the peptide agonist SMS 201-995 for the SSTR2 somatostatin receptor. EMBO J. 1995, 14, 727-735.
14. Srkalovic, G.; Cai, R. Z.; Schally, A. V. Evaluation of receptors for somatostatin in various tumors using different analogs. J. Clin. Endocrinol. Metab. 1990, 70, 661-669.
15. Weckbecker, G.; Raulf, F.; Stolz, B.; Bruns, C. Somatostatin analogs for diagnosis and treatment of cancer. Pharmacol. Ther. 1993, 60, 245-264.
16. Hofland, L. J.; Visser-Wisselaar, H. A.; Lamberts, S. W. Somatostatin analogs: clinical application in relation to human somatostatin receptor subtypes. Biochem. Pharmacol. 1995, 50, 287-297.
17. Keri, G.; Erchegyi, J.; Horvath, A.; Mezo, I.; Idei, M.; Vantus, T.; Balogh, A.; Vadasz, Z.; Bokonyi, G.; Seprodi, J.; Teplan, I.; Csuka, O.; Tejeda, M.; Gaai, D.; Szegedi, Z.; Szende, B.; Roze, C.; Kalthoff, H.; Ullrich, A. A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 12513-12518.
18. Keri, G.; Mezo, I.; Vadasz, Z.; Horvath, A.; Idei, M.; Vantus, T.; Balogh, A.; Bokonyi, G.; Bajor, T.; Teplan, I.; Tamas, J.; Mak, M.; Horvath, J.; Csuka, O. Structure-activity relationship studies of novel somatostatin analogs with antitumor activity. Pept. Res. 1993, 6, 281-288.
19. Stetak, A.; Lankenau, A.; Vantus, T.; Csermely, P.; Ullrich, A.; Keri, G. The antitumor somatostatin analogue TT-232 induces cell cycle arrest through PKCδ and c-Src. Biochem. Biophys. Res. Commun. 2001, 285, 483-488.
20. Vantus, T.; Keri, G.; Krivickiene, Z.; Valius, M.; Stetak, A.; Keppens, S.; Csermely, P.; Bauer, I. P.; Bokonyi, G.; Declercq, W.; Vandenabeele, P.; Merlevede, W.; Vandenheede, R. J. The somatostatin analogue TT-232 induces apoptosis in A431 cells sustained activation of stress-activated kinases and inhibition of signaling to extracellular signal-regulated kinases. Cell. Signalling 2001, 13, 717-725.
21. Miyazaki, A.; Yokoi, T.; Tachibana, Y.; Enomoto, R.; Lee, E.; Bokonyi, G.; Keri, G.; Tsuda, Y.; Okada, Y. Design and synthesis of novel type somatostatin analogs with antiproliferative activities on A431 tumor cells. Tetrahedron Lett. 2004, 45, 6323-6327.
22. Mosmann, T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.